Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Keratosis, Actinic 1Carcinoma, Basal Cell 1

Interventions

Nivolumab 3HhAntag691 3Biopsy 3relatlimab 2pembrolizumab 2cemiplimab 2Specimen Handling 2Radiotherapy 2Observation 2Niacinamide 2Magnetic Resonance Spectroscopy 2Ipilimumab 2sonidegib 1prednylidene 1deltacortene 1daromun 1X-Rays 1Watchful Waiting 1Surgical Procedures, Operative 1Sunscreening Agents 1Standard of Care 1Sirolimus 1Second Harmonic Generation Microscopy 1Prednisone 1Predictive Learning Models 1Practice Guidelines as Topic 1Opdualag 1Interleukin-2 1Immunoglobulin G 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Basal Cell × Sunscreening Agents × Clear all
NCT07286318 2026-06-05

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

University of Pittsburgh

Phase EARLY_PHASE1 Recruiting
20 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡